Jenna Borok is a Dermatology physician affiliated with Northwestern University. OpenAlex indexes 33 publications with 1,090 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
225 E Chicago Ave # 2
Chicago, IL 606112991
Telephone
312-227-6479Provider last certified this registry record 3 Oct 2022.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year202510 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year20254 payments
- Regeneron Healthcare Solutions, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
57.7%Azole Antifungal38.7%Ketoconazole100%Part D≥25 patientsTetracycline-class Drug10.9%Doxycycline Hyclate100%Part D<11 patients+ 1 more class in this area
Dermatology
17.5%Corticosteroid17.5%Triamcinolone Acetonide100%Part D≥23 patientsRespiratory
16.1%RNA Synthetase Inhibitor Antibacterial16.1%Mupirocin100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence
Journal of the American Academy of Dermatology
2024 - Severe acne and its variants: Exploring its natural history and heritability
Pediatric Dermatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”